The biotech uses its AI platform to discover the therapeutic potential of plant-based molecules, advancing ten candidates ...

BEIJING, CHINA - Media OutReach Newswire - 22 November 2024 - The 2024 Beijing Changping Forum on Life Science, themed ...

However, the company couldn't convince the FDA through a series of meetings and resubmissions. Investors' confidence in Y-mAbs suffered a serious blow in October 2022 when the FDA, after months of ...

The Allahabad High Court on Thursday directed the Central Bureau of Investigation (CBI) to investigate the conduct of a ...

In buying Westlake-backed Kate Therapeutics, Novartis gets a handful of preclinical gene therapies targeting diseases like ...

Venture capital firms incubate, grow and finance dozens of drug companies each year. Follow the money they channel into the ...

Enveda, a company using artificial intelligence to boost nature-based drug discovery, is envisioning clinical success with a ...

AI is finding its way into every corner of biotech and pharmaceutical research, but like other industries, it's never quite as straightforward to ...

Pfizer has found a successor for Chief Scientific Officer and R&D head Mikael Dolsten, M.D., Ph.D., tapping the company’s own ...

Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.

Since Abcam's acquisition in 2023, founder Jonathan Milner has been making waves with his investment strategy. Discover his ...